US Patent Issued to ModernaTX on March 18 for "Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,704, issued on March 18, was assigned to ModernaTX Inc. (Cambridge, Mass.).

"Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1" was invented by Paolo Martini (Boston), Stephen Hoge (Cambridge, Mass.), Kerry Benenato (Cambridge, Mass.), Vladimir Presnyak (Manchester, N.H.), Iain McFadyen (Medford, Mass.), Ellalahewage Sathyajith Kumarasinghe (Cambridge, Mass.), Ding An (Waban, Mass.) and Staci Sabnis (Medford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to mRNA therapy for the treatment of galactosemia type 1 (Gal-1). mRNAs for use in the invention, when adminis...